Iskandar Agustin, Mayashinta Dearikha K, Robert Robert, Samsu Nur, Endharti Agustina Tri, Widjajanto Edy
Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya/Saiful Anwar General Hospital, Malang, Indonesia.
Department of Parasitology, Faculty of Medicine, Universitas Brawijaya/Saiful Anwar General Hospital, Malang, Indonesia.
Int J Gen Med. 2023 Jun 8;16:2349-2354. doi: 10.2147/IJGM.S412070. eCollection 2023.
COVID-19 is caused by SARS-CoV-2 and has a wide range of symptoms. While Diabetes Mellitus (DM) is a common comorbidity in COVID-19 patients, it is the main comorbidity in non-surviving COVID-19 patients. Interleukin-8 (IL-8) is a cytokine that has been correlated with severity and mortality in COVID-19 patients, but its role in COVID-19 patients with DM comorbidity and its relationship with NLR and CRP as markers of inflammation are not yet fully understood.
To investigate the correlation between IL-8, NLR, and CRP in COVID-19 patients with DM comorbidity.
A cross-sectional study was conducted at the Integrated Infectious Disease Installation of Dr. Saiful Anwar Malang Hospital from June to November 2021 using consecutive sampling. IL-8 was measured using the ELISA method with Legendmax Human IL-8. NLR was measured using flow cytometry, while CRP was measured using the immunoturbidimetric method with Cobas C6000. Patient outcomes were obtained from medical records.
A total of 124 research subjects participated in the study. IL-8 and CRP levels were significantly higher (p < 0.05) in COVID-19 patients with DM comorbidity, and were also significantly higher (p < 0.05) in non-surviving COVID-19 patients. Overall, there was a positive correlation between IL-8 and CRP (r = 0.58, p < 0.05). There was also a positive correlation between IL-8 (r = 0.58; p < 0.05), NLR (r = 0.45, p < 0.05), CRP (r = 0.54, p < 0.05) and mortality in COVID-19 patients with DM comorbidity. The presence of DM comorbidity increased IL-8 levels and aggravated inflammation in COVID-19 patients, thereby increasing the risk of mortality.
IL-8, CRP and NLR levels were higher in non-surviving COVID-19 patients with DM comorbidity, indicating that they could serve as good predictors of poor outcomes in this patient population.
新型冠状病毒肺炎(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,症状多样。糖尿病(DM)是COVID-19患者常见的合并症,也是COVID-19死亡患者的主要合并症。白细胞介素-8(IL-8)是一种细胞因子,与COVID-19患者的病情严重程度和死亡率相关,但其在合并DM的COVID-19患者中的作用以及与作为炎症标志物的中性粒细胞与淋巴细胞比值(NLR)和C反应蛋白(CRP)的关系尚未完全明确。
探讨合并DM的COVID-19患者中IL-8、NLR和CRP之间的相关性。
2021年6月至11月,在赛义夫·安瓦尔博士玛琅医院综合传染病科采用连续抽样法进行横断面研究。使用Legendmax人IL-8酶联免疫吸附测定(ELISA)法检测IL-8。采用流式细胞术检测NLR,使用Cobas C6000免疫比浊法检测CRP。患者结局从病历中获取。
共有124名研究对象参与研究。合并DM的COVID-19患者的IL-8和CRP水平显著更高(p<0.05),在COVID-19死亡患者中也显著更高(p<0.05)。总体而言,IL-8与CRP之间存在正相关(r=0.58,p<0.05)。在合并DM的COVID-19患者中,IL-8(r=0.58;p<0.05)、NLR(r=0.45,p<0.05)、CRP(r=0.54,p<0.05)与死亡率之间也存在正相关。合并DM会增加COVID-19患者的IL-8水平并加重炎症,从而增加死亡风险。
合并DM的COVID-19死亡患者的IL-8、CRP和NLR水平更高,表明它们可作为该患者群体不良结局的良好预测指标。